Medical Devices & Tech

TearLab Corporation

11021 Roselle St., Suite 100
San Diego, CA 92121 USA
Click for website

Research Sector Medical Devices & Tech

Summary Description Point of care diagnostics for ocular diseases

Management Elias Vamvakas, Chief Executive Officer; Michael A. Lemp, M.D., F.A.C.S., Chief Medical Officer; Benjamin Sullivan, Ph.D., Chief Scientific Officer; Bob Walder, PA-C, Vice President, Operations; Michael Berg, Vice President Clinical & Regulatory; Steve Zmina, Vice President Manufacturing & Engineering; Tracy Puckett, Vice President Marketing

Click here for Financial Data
Keywords: ophthalmology, eye, vision, eye disease, dry eye, diagnostic, lab-on-a-chip,


Updated: Aug. 22, 2013


TearLab Corporation ( develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by quantitatively testing for disease marker......view more

Products / Services

The TearLab(TM) Osmolarity System provides the first quantitative and objective diagnostic technology that allows doctors to effectively manage their dry eye patients. TearLab will allow practitioner......view more

Technology / Differentiation

TearLab Corporation's core technology is rooted in nanofluidics and electrochemical detection. The Company owns or has exclusively licensed numerous issued and pending patent applications that broadly...view more

Market / Customers

Dry Eye Disease (DED) is a chronic, progressive disease. Morgan Stanley's Dry Eye Market Report (2003) estimates that 30 to 60 million Americans suffer from dry eye symptoms. Only 10 million are diagn......view more


Headquartered in San Diego, CA and with offices in Milton, Ontario and Alpharetta, GA, TearLab Corporation's common shares trade on the NASDAQ Global Market under the symbol 'TEAR' and on the Toronto ...view more

Analyst Coverage